Showing results (2371-2380 of 2,814) with videos related to

Sort By:
Pageof 282
Plos One|May 27, 2014
Asymptomatic Plasmodium falciparum malaria in pregnant women in the Chittagong Hill Districts of BangladeshWasif A Khan, Sean R Galagan, Chai Shwai Prue, et al.
Stroke|August 28, 2024
Psychosocial Health and the Association Between Cerebral Small Vessel Disease Markers With Dementia: The ARIC StudySurabhee Eswaran, David S Knopman, Silvia Koton, et al.
Plos One|October 1, 2015
Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan EbolavirusesCallie E Bounds, Steven A Kwilas, Ana I Kuehne, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 31, 2025
Plasma proteomic characterization of motoric cognitive risk and mild cognitive impairmentGabriela T Gomez, Sanish Sathyan, Jingsha Chen, et al.
Plos One|January 29, 2016
Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic ReviewLauralyn A McIntyre, David Moher, Dean A Fergusson, et al.
Cancer Immunology Research|March 5, 2015
Impact of NRAS mutations for patients with advanced melanoma treated with immune therapiesDouglas B Johnson, Christine M Lovly, Marisa Flavin, et al.
Plos One|August 13, 2013
Malaria hotspots drive hypoendemic transmission in the Chittagong Hill Districts of BangladeshSabeena Ahmed, Sean Galagan, Heather Scobie, et al.
Journal for Immunotherapy of Cancer|November 13, 2021
Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trialPatrick A Ott, Matthew Nazzaro, Kathleen L Pfaff, et al.
Journal of the American Heart Association|November 26, 2025
Immune Checkpoint Inhibitors, Atherosclerotic Cardiovascular Events, and Plaque Progression Among Women With CancerGiselle Alexandra Suero-Abreu, Zsofia D Drobni, Carlos A Gongora, et al.
Oncoimmunology|May 4, 2018
A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanomaMeghan J Mooradian, Alexandre Reuben, Peter A Prieto, et al.
Pageof 282